These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 7956454

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum.
    Kobayashi S, Arai S, Hayashi S, Fujimoto K.
    Antimicrob Agents Chemother; 1986 Nov; 30(5):713-8. PubMed ID: 3492175
    [Abstract] [Full Text] [Related]

  • 23. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
    Jarlier V, Nicolas MH, Philippon A, Giroir AM, Grosset J.
    J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [In vitro antimicrobial activity of cefpirome compared to other broad-spectrum beta-lactam drugs against 804 clinical isolates from 9 Brazilian hospitals].
    Sader HS, Mendes CM, Montelli A, Sampaio J, Segura AJ, Kesselring GL, Costa L, Ribeiro JE, Mamizuka E, Mimiça I.
    Rev Assoc Med Bras (1992); 1998 Aug; 44(4):283-8. PubMed ID: 9852647
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of a disk approximation test of inducible beta-lactamases in Enterobacteriacae and Pseudomonas aeruginosa.
    Thore M, Jalakas K, Eriksson I, Dornbusch K.
    APMIS; 1989 Apr; 97(4):317-24. PubMed ID: 2497754
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cefpirome Treatment Results in Limited Selection of Stable Derepressed Enterobacter cloacae Mutants in the Intestinal Flora of Rats Treated for an Experimental Klebsiella pneumoniae Pulmonary Infection.
    Gautam V, Mouton JW, Ten Kate MT, Bakker-Woudenberg IAJM, van Burgh S, Strepis N, Klaassen CHW, Goessens W.
    Microb Drug Resist; 2020 Apr; 26(4):341-348. PubMed ID: 31657651
    [Abstract] [Full Text] [Related]

  • 29. In vitro activity of cefpirome against selected clinical enterobacterial isolates with beta-lactamase-mediated resistance.
    Tzouvelekis LS, Tzelepi E, Mentis AF, Legakis NJ.
    Infection; 1995 Apr; 23(6):384-7. PubMed ID: 8655212
    [Abstract] [Full Text] [Related]

  • 30. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R, Mittermayer H, Feierl G, Allerberger F, Wendelin I, Hirschl A, Reisinger EC.
    Wien Klin Wochenschr; 1999 Jul 30; 111(14):549-54. PubMed ID: 10467641
    [Abstract] [Full Text] [Related]

  • 31. Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase.
    Kohlmann R, Bähr T, Gatermann SG.
    J Antimicrob Chemother; 2018 Jun 01; 73(6):1530-1536. PubMed ID: 29566147
    [Abstract] [Full Text] [Related]

  • 32. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA, Tawfik AF, Shibl AM.
    Chemotherapy; 1995 Jun 01; 41(3):193-9. PubMed ID: 7656665
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Selection of beta-lactamase producers during cephalosporin and penicillin therapy.
    Wiedemann B.
    Scand J Infect Dis Suppl; 1986 Jun 01; 49():100-5. PubMed ID: 3103207
    [Abstract] [Full Text] [Related]

  • 35. Induction of plasmid-mediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in Enterobacteriaceae.
    Akata K, Muratani T, Yatera K, Naito K, Noguchi S, Yamasaki K, Kawanami T, Kido T, Mukae H.
    PLoS One; 2019 Jun 01; 14(7):e0218589. PubMed ID: 31283769
    [Abstract] [Full Text] [Related]

  • 36. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM.
    J Antimicrob Chemother; 2007 Aug 01; 60(2):300-11. PubMed ID: 17548456
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases.
    Akova M, Yang Y, Livermore DM.
    J Antimicrob Chemother; 1990 Feb 01; 25(2):199-208. PubMed ID: 2158496
    [Abstract] [Full Text] [Related]

  • 39. Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.
    Curtis NA, Eisenstadt RL, Rudd C, White AJ.
    J Antimicrob Chemother; 1986 Jan 01; 17(1):51-61. PubMed ID: 3485092
    [Abstract] [Full Text] [Related]

  • 40. Inactivation of cephalosporins by beta-lactamases of gram-negative rods.
    Bauernfeind A, Petermüller C, Jungwirth R.
    Infection; 1983 Jan 01; 11 Suppl 1():S39-43. PubMed ID: 6339417
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.